Flynn F V, Lapsley M, Sansom P A, Cohen S L
Department of Chemical Pathology, University College and Middlesex School of Medicine, London.
J Clin Pathol. 1992 Jul;45(7):561-7. doi: 10.1136/jcp.45.7.561.
To determine whether urinary beta 2-glycoprotein-1 assays can provide improved discrimination between chronic renal diseases which are primarily of tubular or glomerular origin.
Urinary beta 2-glycoprotein-1, retinol-binding protein, alpha 1-microglobulin, beta 2-microglobulin, N-acetyl-beta-D-glucosa-minidase and albumin were measured in 51 patients with primary glomerular disease, 23 with obstructive nephropathy, and 15 with polycystic kidney disease, and expressed per mmol of creatinine. Plasma beta 2-glycoprotein-1 was assayed in 52 patients and plasma creatinine in all 89. The findings were compared between the diagnostic groups and with previously published data relating to primary tubular disorders.
All 31 patients with plasma creatinine greater than 200 mumol/l excreted increased amounts of beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin, and 29 had increased N-acetyl-beta-D-glucosaminidase; the quantities were generally similar to those found in comparable patients with primary tubular pathology. Among 58 with plasma creatinine concentrations under 200 mumol/l, increases in beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin excretion were less common and much smaller, especially in those with obstructive nephropathy and polycystic disease. The ratios of the excretion of albumin to the other proteins provided the clearest discrimination between the patients with glomerular or tubular malfunction, but an area of overlap was present which embraced those with obstructive nephropathy and polycystic disease.
Increased excretion of beta 2-glycoprotein-1 due to a raised plasma concentration or diminution of tubular reabsorption, or both, is common in all the forms of renal disease investigated, and both plasma creatinine and urinary albumin must be taken into account when interpreting results. Ratios of urinary albumin: beta 2-glycoprotein-1 greater than 1000 are highly suggestive of primary glomerular disease and those less than 40 of primary tubular disease. Used in this way, beta 2-glycoprotein-1 assays provide superior discrimination between glomerular and tubular malfunction when compared with retinol binding protein but the best discrimination is provided by albumin: alpha 1-microglobulin ratios.
确定尿β2-糖蛋白-1检测能否更好地区分主要源于肾小管或肾小球的慢性肾脏疾病。
检测了51例原发性肾小球疾病患者、23例梗阻性肾病患者和15例多囊肾病患者的尿β2-糖蛋白-1、视黄醇结合蛋白、α1-微球蛋白、β2-微球蛋白、N-乙酰-β-D-氨基葡萄糖苷酶和白蛋白,并以每毫摩尔肌酐表示。检测了52例患者的血浆β2-糖蛋白-1,所有89例患者均检测了血浆肌酐。对各诊断组的结果进行了比较,并与先前发表的有关原发性肾小管疾病的数据进行了比较。
所有31例血浆肌酐大于200μmol/L的患者,β2-糖蛋白-1、视黄醇结合蛋白和α1-微球蛋白的排泄量均增加,29例N-乙酰-β-D-氨基葡萄糖苷酶增加;其数量通常与原发性肾小管病变的类似患者中发现的数量相似。在58例血浆肌酐浓度低于200μmol/L的患者中,β2-糖蛋白-1、视黄醇结合蛋白和α1-微球蛋白排泄增加的情况较少见且增加幅度较小,尤其是在梗阻性肾病和多囊肾病患者中。白蛋白与其他蛋白质的排泄比值最能清晰地区分肾小球或肾小管功能障碍患者,但存在一个重叠区域,包括梗阻性肾病和多囊肾病患者。
在所有研究的肾脏疾病形式中,由于血浆浓度升高或肾小管重吸收减少或两者兼而有之导致的β2-糖蛋白-1排泄增加都很常见,在解释结果时必须同时考虑血浆肌酐和尿白蛋白。尿白蛋白:β2-糖蛋白-1比值大于1000高度提示原发性肾小球疾病,小于40提示原发性肾小管疾病。以这种方式使用时,与视黄醇结合蛋白相比,β2-糖蛋白-1检测在区分肾小球和肾小管功能障碍方面具有更好的鉴别能力,但白蛋白:α1-微球蛋白比值的鉴别能力最佳。